Finance

Lists
FRX:TSE
Fennec Pharmaceuticals Inc
CA$14.86
0.00%
(0.00) 1D
Oct 7, 12:46:18 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for FRX...
Mkt. cap
530.12M
Avg. vol.
476.00
Volume
0.00
52-wk high
CA$17.64
52-wk low
CA$7.59
EPS
-CA$0.17
Beta
1.05
Shares outstanding
35.07M
No. of employees
35
Mkt. cap
530.12M
Avg. vol.
476.00
Volume
0.00
52-wk high
CA$17.64
52-wk low
CA$7.59
EPS
-CA$0.17
Beta
1.05
Shares outstanding
35.07M
No. of employees
35
News stories
From web sources and news partners
About Fennec Pharmaceuticals Inc
CEO-
Employees35
Founded1996
HeadquartersDurham, North Carolina, United States
SectorBiotechnology
Websitefennecpharma.com
Last report
Aug 11, 2026
Fiscal period
Q2 2026
- / $0.02
Revenue / Est. (USD)
17.87M / 16.12M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
12.46M
13.78M
15.11M
17.87M
Cost of goods sold
660.00K
1.76M
570.00K
721.00K
Cost of revenue
660.00K
1.76M
570.00K
721.00K
Research and development expenses
29.00K
20.00K
49.00K
118.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.96M
14.55M
14.61M
15.30M
Operating expense
11.99M
14.57M
14.66M
15.42M
Total operating expenses
12.65M
16.33M
15.23M
16.14M
Operating income
-189.00K
-2.55M
-119.00K
1.74M
Other non operating income
-
-
-
-
EBT including unusual items
-638.00K
-4.68M
201.00K
2.02M
EBT excluding unusual items
-638.00K
-2.66M
201.00K
2.02M
Income tax expense
-
106.00K
-
42.00K
Effective tax rate
-
-2.26%
-
2.08%
Other operating expenses
-
-
-
-
Net income
-638.00K
-4.79M
201.00K
1.97M
Net profit margin
-5.12%
-34.75%
1.33%
11.04%
Earnings per share
-0.02
-0.10
-
-
Interest and investment income
152.00K
228.00K
339.00K
287.00K
Interest expense
-598.00K
-334.00K
-7.00K
-3.00K
Net interest expenses
-446.00K
-106.00K
332.00K
284.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-163.00K
-2.53M
-93.00K
1.76M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps